tirzepatide cardiovascular outcomes trial results july 2025 Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and Tirzepatide Matches Dulaglutide in Large

Description

Talk to your healthcare provider first

Foods to Avoid When Prone to Sulfur Burps Certain foods are notorious triggers worth avoiding if youre susceptible to sulfur burps

Signs that you should pause escalation include persistent nausea lasting more than 3 days after injection, vomiting more than once per week, diarrhea that interferes with daily activities, or significant appetite loss that makes it difficult to consume adequate protein and nutrients

Study cohorts We designed five active-comparator, new-user cohort studies including patients with obesity and type 2 diabetes at elevated cardiovascular risk 46

Mounjaro (tirzepatide) represents a groundbreaking advancement in diabetes and weight loss treatment, offering patients a dual-action approach to managing these interconnected health conditions